Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Talphera Inc (TLPH)

Talphera Inc (TLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Talphera Inc 1850 Gateway Drive Suite 175 San Mateo CA 94404 USA

https://talphera.com Employees: 13 P: 650-216-3500

Sector:

Medical

Description:

Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 51,271
Enterprise Value, $K 42,411
Shares Outstanding, K 46,610
Annual Sales, $ 0 K
Annual Net Income, $ -13,000 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,490 K
EBIT, $ -13,360 K
EBITDA, $ -13,480 K
60-Month Beta 0.25
% of Insider Shareholders 5.70%
% of Institutional Shareholders 37.67%
Float, K 43,953
% Float 94.30%
Short Interest 2,039
Short Float 4.38%
Short Volume Ratio 0.33

Growth:

1-Year Return 101.89%
3-Year Return -50.92%
5-Year Return -96.04%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 96.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/12/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.40
EPS Growth vs. Prev Qtr -10.00%
EPS Growth vs. Prev Year 15.38%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/26/22

TLPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -126.49%
Return-on-Assets % -61.93%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 1,229.16
Price/Cash Flow N/A
Price/Book 2.75
Book Value/Share 0.32
Interest Coverage -32.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar